Nuveen Asset Management, LLC Fortress Biotech, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $137,256 - $257,356	-171,571 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.24 - $2.75 $642 - $1,424	518 Added 0.3%	171,571 $243,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $46,229 - $69,725	-19,103 Reduced 10.05%	171,053 $416,000
Q3 2021 Nov 12, 2021	SELL	$2.82 - $3.7 $149,068 - $195,585	-52,861 Reduced 21.75%	190,156 $637,000
Q2 2021 Aug 16, 2021	SELL	$3.5 - $5.48 $71,694 - $112,252	-20,484 Reduced 7.77%	243,017 $867,000
Q1 2021 May 17, 2021	BUY	$3.16 - $4.89 $14,043 - $21,731	4,444 Added 1.72%	263,501 $930,000
Q4 2020 Feb 16, 2021	SELL	$2.2 - $4.45 $125,103 - $253,049	-56,865 Reduced 18.0%	259,057 $821,000
Q3 2020 Nov 16, 2020	BUY	$2.62 - $4.78 $98,760 - $180,182	37,695 Added 13.55%	315,922 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$1.83 - $3.16 $509,155 - $879,197	278,227 New	278,227 $746,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $169M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.